UY26986A1 - (7-(3-carboxifenil)-4-cloroisoquinolin-1-il) guanidina - Google Patents

(7-(3-carboxifenil)-4-cloroisoquinolin-1-il) guanidina

Info

Publication number
UY26986A1
UY26986A1 UY26986A UY26986A UY26986A1 UY 26986 A1 UY26986 A1 UY 26986A1 UY 26986 A UY26986 A UY 26986A UY 26986 A UY26986 A UY 26986A UY 26986 A1 UY26986 A1 UY 26986A1
Authority
UY
Uruguay
Prior art keywords
chloroisoquinolin
guanidine
carboxifenil
carboxyphenyl
intermediates
Prior art date
Application number
UY26986A
Other languages
English (en)
Inventor
Trevor Jack Newbury
Paul Vincent Fish
Anne Bruckner
Michael Butters
Michael Paul Fitzgerald
Julie Ann Macrae
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of UY26986A1 publication Critical patent/UY26986A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención descrita en el presente documento se refiere a un procedimiento para la preparación de (7-(3-carboxifenil)-4-cloroisoquinolin-1-il) guanidina (I), intermedios para el mismo y nuevas formas y formulaciones del mismo, incluyendo el monohidrato de ion dipolar (I), adecuadas para el uso farmacéutico.
UY26986A 2000-10-30 2001-10-26 (7-(3-carboxifenil)-4-cloroisoquinolin-1-il) guanidina UY26986A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0026490.3A GB0026490D0 (en) 2000-10-30 2000-10-30 Process

Publications (1)

Publication Number Publication Date
UY26986A1 true UY26986A1 (es) 2002-06-20

Family

ID=9902194

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26986A UY26986A1 (es) 2000-10-30 2001-10-26 (7-(3-carboxifenil)-4-cloroisoquinolin-1-il) guanidina

Country Status (16)

Country Link
US (1) US6645979B2 (es)
EP (1) EP1330439A1 (es)
JP (1) JP2004513119A (es)
AP (1) AP2001002320A0 (es)
AU (1) AU2002210820A1 (es)
BR (1) BR0114330A (es)
CA (1) CA2427613A1 (es)
GB (1) GB0026490D0 (es)
HN (1) HN2001000246A (es)
MX (1) MXPA03003928A (es)
PA (1) PA8528801A1 (es)
PE (1) PE20020517A1 (es)
SV (1) SV2003000707A (es)
TN (1) TNSN01152A1 (es)
UY (1) UY26986A1 (es)
WO (1) WO2002036571A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2167329T3 (es) * 1992-01-31 2002-05-16 Chugai Pharmaceutical Co Ltd Cristal de hidrato de derivado de acido quinolonacarboxilico.
CA2125246C (en) 1993-06-07 2001-07-03 Junichi Imuta Transition metal compound and olefin polymerization catalyst using the same
GB9721964D0 (en) * 1997-10-16 1997-12-17 Pfizer Ltd Isoquinolines

Also Published As

Publication number Publication date
EP1330439A1 (en) 2003-07-30
GB0026490D0 (en) 2000-12-13
MXPA03003928A (es) 2003-08-19
AP2001002320A0 (en) 2001-12-31
CA2427613A1 (en) 2002-05-10
US6645979B2 (en) 2003-11-11
HN2001000246A (es) 2002-05-08
PA8528801A1 (es) 2002-08-26
BR0114330A (pt) 2003-08-26
US20020077336A1 (en) 2002-06-20
SV2003000707A (es) 2003-01-13
TNSN01152A1 (en) 2005-11-10
WO2002036571A1 (en) 2002-05-10
JP2004513119A (ja) 2004-04-30
AU2002210820A1 (en) 2002-05-15
PE20020517A1 (es) 2002-06-20

Similar Documents

Publication Publication Date Title
AR037109A1 (es) Uso de flibanserina
UY27740A1 (es) Nuevos compuestos
PA8565101A1 (es) Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo
HN2004000319A (es) "{ 1,8}naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia"
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
HN2002000266A (es) Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad.
HN2001000006A (es) Antagonistas del factor liberador de corticotropina
UY28342A1 (es) Nuevos compuestos
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
HN1999000124A (es) Derivados de pirazol substituido.
HN2001000019A (es) Derivados de nicotinamida benzocondensada heterociclico utiles como inhibidores selectivos de las isozimas pde4.
HN2001000192A (es) Derivados de pirazol
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
PT1259512E (pt) Compostos de pteridin para o tratamento da psoriase
SE0301653D0 (sv) Novel compounds
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
AR040130A1 (es) Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos
SV2009003403A (es) Extrudidos con enmascaramiento del sabor mejorado
UY27275A1 (es) Composiciones y metodos para aumentar la biodisponibilidad de agentes farmacéuticos
SE0102716D0 (sv) Novel compounds
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
UY26986A1 (es) (7-(3-carboxifenil)-4-cloroisoquinolin-1-il) guanidina
DOP2001000269A (es) (7-(3-carboxifenil)-4-cloroisoquinolin-1-il)guanidina.
SV2003001061A (es) Nuevos heterociclos 3 ref.lea 35361-sv
ECSP088236A (es) Formas y composiciones de dosificaciones farmacéuticas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141121